✦ LIBER ✦

The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma

✍ Scribed by T. Michael Numnum; Rodney P. Rocconi; Jenny Whitworth; Mack N. Barnes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of bevacizumab in refractory ova

✍ Joshua P. Kesterson; Paulette Mhawech-Fauceglia; Shashikant Lele 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Intraperitoneal bevacizumab for the pall

✍ Chad A. Hamilton; G. Larry Maxwell; Mildred R. Chernofsky; Sarah A. Bernstein; J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 134 KB

A Randomized Trial of Paracentesis plus

✍ H.W. Hirte; D. Miller; K. Tonkin; B. Findlay; V. Capstick; J. Murphy; R. Buckman 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Phase II study of bevacizumab and erloti

✍ Thomas Yau, Hilda Wong, Pierre Chan, T. J. Yao, R. Pang, T. T. Cheung, S. T. Fan 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 156 KB

The use of terlipressin in cirrhotic pat

✍ Basilio Fimiani; Domenico Della Guardia; Claudio Puoti; Giuseppe D' Adamo; Olimp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Use of Pelvic Lymphoscintigraphy to Demo

✍ Dom-Gene Tu; Wei-Jen Yao; Yi-Hsun Chen; Shu-Mu Hwang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 595 KB